Company Overview and News

 
Closing Bell: Sensex rises 108 pts, Nifty ends above 10,150; banks, financials lead

2018-03-27 moneycontrol
3:30 pm Market Closing: Benchmark indices continued to trade higher for second consecutive session, with the Sensex rising 107.98 points to 33,174.39, tracking positive move in global equities.

 
Market Live: Sensex up over 150 pts, Europe strong; PSU banks outperform, SBI up 3%

2018-03-27 moneycontrol
2:10 pm Government Investment in IOB: Indian Overseas Bank informed exchanges that it has received an amount of Rs 388.94 crore on March 26, 2018 towards contribution of the Central Government in the preferential allotment of equity shares of the bank during the FY18, as Government's investment.

 
Market Live: Sensex, Nifty mildly higher; Eicher Motors, HPCL, BPCL, Bajaj Fin up 2-3%

2018-03-27 moneycontrol
12:40 pm Europe Trade: European equities opened higher as concerns over a global trade war eased.

 
Not in position to pay interest on Rs 200-cr NCD: Ricoh India

2018-03-10 moneycontrol
Ricoh India today said it is "not in the position" to pay the half yearly interest on the Rs 200 crore non-convertible debentures issued by the company to Ricoh Asia Pacific.

 
Ricoh accounting fraud: SEBI bans 7 from securities market

2018-02-13 thehindubusinessline
Markets regulator SEBI has banned seven people, including Ricoh India MD and Chief Executive AT Rajan, from the securities market for falsifying the company’s accounts.

 
Sebi passes interim order in Ricoh India accounting fraud case

2018-02-13 livemint
Mumbai: The Securities and Exchange Board of India (Sebi) on Monday passed an interim order in the case of fund diversion and falsifying books of Ricoh India Ltd.

 
Sebi orders forensic audit of Ricoh India's books, bans six individuals

2018-02-12 business-standard
The Securities and Exchange Board of India (Sebi) has ordered a detailed forensic audit of Ricoh India’s books since 2012-13. The regulator has also imposed securities market ban on six individuals associated with the company, including its erstwhile managing director and chief executive officers T Takano and Manoj Kumar, respectively. The case involves fraud at the Japan-based Ricoh’s Indian arm.

 
Veteran fund manager#39;s advice for small retail investors: Invest in learning about investing

2018-02-10 moneycontrol
Research analysts and fund managers these days have access to various tools and software to analyze a company or to run a query. Within seconds the output throws up companies that meet their conditions.

 
News Live: Beating Retreat Ceremony kicks off marking the end of Republic Day celebrations

2018-01-29 moneycontrol
More than half of the professionals responded to a survey expect a 500 basis points cut in corporate tax to 25% in the Budget which will be presented on Thursday, reports PTI. According to a survey by Deloitte covering 120 professionals across the sectors, close to 50% feel that tax reforms, particularly tax litigation, should be the most critical priority now for government. This is followed by reforms in the real estate sector.

 
Ricoh India files for insolvency

2018-01-29 moneycontrol
Japanese imaging and electronics majors Indian subsidiary Ricoh India has filed for insolvency proceedings as it is unable to meet its liabilities.

 
Japanese electronics major arm Ricoh India files for insolvency

2018-01-29 thehindubusinessline
Press Trust of India Japanese imaging and electronics majors Indian subsidiary Ricoh India has filed for insolvency proceedings as it is unable to meet its liabilities.

 
News Live: 50% professionals expect steep cut in corp tax in Budget 2018, says survey

2018-01-29 moneycontrol
More than half of the professionals responded to a survey expect a 500 basis points cut in corporate tax to 25% in the Budget which will be presented on Thursday, reports PTI. According to a survey by Deloitte covering 120 professionals across the sectors, close to 50% feel that tax reforms, particularly tax litigation, should be the most critical priority now for government. This is followed by reforms in the real estate sector.

 
Ricoh India parent cuts off financial support: What it means for investors

2017-10-31 moneycontrol
Ricoh India is in focus today on news that parent, Ricoh Global which holds more than 73 percent stake in the Indian company, will cut off all financial support.

 
India Output Management Software Market for SME Segment 2016-2022: Market is Projected to Touch Over $74 Million - Research and Markets

2017-05-05 prnewswire
Research and Markets has announced the addition of the "India Output Management Software Market for SME Segment (2016-2022): Market Forecast by Segments, Regions and Competitive Landscape" report to their offering.

 
Infosys row: Sebi says will not spare anyone if found guilty

2017-02-18 moneycontrol
Ensure that your correct email id and mobile has been registered with moneycontrol. If not, please update your profile and secure the account now. Updating your email id and mobile number offers following benefits:

Related Articles

ACIA: Acacia Communications Analysis and Research Report

6m - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...